Lymphoid Neoplasm — Trials

Lymphoid Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

8,886 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 2,419
Recruiting: 1,267
Ph III recruiting: 131
Growth YoY: +4%
Industry share: 25%
Top sponsor: National Cancer Institute (NCI)
Termination share: 35.2%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,374)

clinicaltrialsPublishedShowing 351–400 of 713 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05735717	MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies	recruiting	Phase 2	70	Masonic Cancer Center, University of MinnesotaOTHER	1	Apr 6, 2026	clinicaltrials
NCT03587844	Dosing of Brentuximab Vedotin for Mycosis Fungoides, Sezary Syndrome Patients	recruiting	Phase 2	58	Memorial Sloan Kettering Cancer CenterOTHER	1	Apr 3, 2026	clinicaltrials